Skip to main content
Regencell Bioscience Holdings Ltd logo

Regencell Bioscience Holdings Ltd — Investor Relations & Filings

Ticker · RGC ISIN · KYG7487R1002 US Manufacturing
Filings indexed 76 across all filing types
Latest filing 2026-03-30 Foreign Filer Report
Country US United States of America
Listing US RGC

About Regencell Bioscience Holdings Ltd

https://www.regencellbioscience.com/

Regencell Bioscience Holdings Ltd. is an early-stage bioscience company that focuses on the research, development, and commercialization of proprietary Traditional Chinese Medicine (TCM) formulations. The company's primary therapeutic focus is on treating neurocognitive and neurodevelopmental disorders, specifically Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD). It aims to develop natural and effective treatments to improve the quality of life for patients and their families, with the goal of becoming a global market leader in this field.

Recent filings

Filing Released Lang Actions
6-K - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
Foreign Filer Report
2026-03-30 English
6-K - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
Foreign Filer Report
2026-03-30 English
424B5 - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
Prospectus
2026-03-30 English
F-3ASR - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
Regulatory Filings
2026-03-30 English
3 - Regencell Bioscience Holdings Ltd (0001829667) (Issuer)
Director's Dealing
2026-03-18 English
3 - Regencell Bioscience Holdings Ltd (0001829667) (Issuer)
Director's Dealing
2026-03-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.